Literature DB >> 30514749

Multiorgan accelerated silicosis misdiagnosed as sarcoidosis in two workers exposed to quartz conglomerate dust.

Gabriella Guarnieri1, Rosana Bizzotto2, Ottorino Gottardo2, Emanuela Velo3, Mauro Cassaro4, Stefania Vio5, Maria Grazia Putzu6, Federica Rossi6, Paolo Zuliani6, Filippo Liviero1, Paola Mason1, Piero Maestrelli1.   

Abstract

INTRODUCTION: Clusters of silicosis cases have been reported in the fabrication of quartz conglomerate, a new high-silica-content artificial stone for kitchen and bathroom benchtops (countertops). AIM: We describe two cases of accelerated-type silicosis with hepatic granulomas arising in workers exposed to artificial quartz conglomerates.
METHODS: A confident diagnosis of multiorgan silicosis was based on high level of respirable silica in the workplace, typical radiological alterations in chest high-resolution CT, histological findings in the lung and liver, and detection of silica crystals in both tissues by phase-contrast polarising light microscopy and scanning electron microscopy and energy dispersive spectroscopy.
RESULTS: The development of the disease <10 years after the first exposure is consistent with an accelerated-type of silicosis. Compared with other studies related to quartz conglomerate exposure, we determined that the levels of airborne crystalline silica during activity in the finishing area were between 0.260 and 0.744 mg/m3, that is, much higher than the threshold limit value according to American Conference of Governmental Industrial Hygienists (0.025 mg/m3). Moreover, liver granulomas were associated with accumulation of crystalline silica particles in the hepatic tissue.
CONCLUSIONS: Quartz conglomerate fabrication is a potentially dangerous occupation. General practitioners and physicians should have awareness of this newly described occupational hazard. Accurate occupational history is critical in avoiding misdiagnosis, as silicosis caused by inhalation of dust from artificial quartz conglomerates may exhibit atypical presentation. These features seem to be related to the extremely high level of silica exposure and, possibly, to an increased toxicity of the dust generated in this process. © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  inorganic dusts; liver; lung function; pathology; pneumoconioses

Mesh:

Substances:

Year:  2018        PMID: 30514749     DOI: 10.1136/oemed-2018-105462

Source DB:  PubMed          Journal:  Occup Environ Med        ISSN: 1351-0711            Impact factor:   4.402


  5 in total

1.  Sarcoidosis and silica dust exposure among men in Sweden: a case-control study.

Authors:  Pål Graff; Johanna Larsson; Ing-Liss Bryngelsson; Pernilla Wiebert; Per Vihlborg
Journal:  BMJ Open       Date:  2020-09-03       Impact factor: 2.692

2.  Artificial Stone Associated Silicosis: A Systematic Review.

Authors:  Veruscka Leso; Luca Fontana; Rosaria Romano; Paola Gervetti; Ivo Iavicoli
Journal:  Int J Environ Res Public Health       Date:  2019-02-16       Impact factor: 3.390

3.  Silicosis in finishing workers in quartz conglomerates processing.

Authors:  Gabriella Guarnieri; Mauro Salasnich; Paolo Lucernoni; Marta Sbaraglia; Maria Grazia Putzu; Paolo Zuliani; Federica Rossi; Stefania Vio; Leonardo Bianchi; Andrea Martinelli; Ottorino Gottardo; Rosanna Bizzotto; Piero Maestrelli; Paola Mason; Mariella Carrieri
Journal:  Med Lav       Date:  2020-04-30       Impact factor: 1.275

4.  Accelerated silicosis with bone marrow, hepatic and splenic involvement in a patient with lung transplantation.

Authors:  M Cruz Carreño Hernández; Sara Garrido Paniagua; María Colomés Iess; Mehdi Guemra
Journal:  BMJ Case Rep       Date:  2019-12-11

5.  Association between Crystalline Silica Dust Exposure and Silicosis Development in Artificial Stone Workers.

Authors:  Mar Requena-Mullor; Raquel Alarcón-Rodríguez; Tesifón Parrón-Carreño; Jose Joaquín Martínez-López; David Lozano-Paniagua; Antonio F Hernández
Journal:  Int J Environ Res Public Health       Date:  2021-05-25       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.